This study investigates the potential of amygdalin, a natural compound found in almonds, peaches, and apples, as a therapeutic agent for HER2-positive ...

Breast cancer incidence trends differ by age, even among older women, particularly by race and ethnicity and stage at ...

With an FDA IND clearance, the firm will test IKS014 as an alternative for HER2-positive solid tumor patients in the US who have relapsed on other therapies.

This year's American Society of Clinical Oncology (ASCO) meeting delivered a packed agenda of breast cancer research, with ...

Abstract: The Human Epidermal Growth Factor Receptor 2 (HER2) is one of the aggressive subtypes of breast cancer. The HER2 status decides the requirement of breast cancer patients to receive ...

Small-molecule irreversible tyrosine kinase inhibitors as high potent agents have led to improvements in disease-free and overall survival in patients with HER2-amplified cancer. The approved ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

HR-positive/HER2-negative is the most common subtype of breast cancer in women. HR-positive/HER2-negative metastatic breast ...

Nearly 40% of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy.